{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:57:48Z","timestamp":1793721468512,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL-118524"],"award-info":[{"award-number":["R01 HL-118524"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 HL-122744"],"award-info":[{"award-number":["R01 HL-122744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10741-017-9660-1","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T03:56:31Z","timestamp":1509681391000},"page":"499-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Pharmacological heart rate lowering in patients with a preserved ejection fraction\u2014review of a failing concept"],"prefix":"10.1007","volume":"23","author":[{"given":"Markus","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Rambod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"LeWinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"9660_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","volume":"50","author":"K Fox","year":"2007","unstructured":"Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M (2007) Resting heart rate in cardiovascular disease. Heart Rate Working Group. J Am Coll Cardiol 50:823\u2013830","journal-title":"J Am Coll Cardiol"},{"key":"9660_CR2","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1056\/NEJMoa043012","volume":"352","author":"X Jouven","year":"2005","unstructured":"Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P (2005) Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352:1951\u20131958","journal-title":"N Engl J Med"},{"key":"9660_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1085\/jgp.20028593","volume":"120","author":"A Bucchi","year":"2002","unstructured":"Bucchi A, Baruscotti M, DiFrancesco D (2002) Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine. J Gen Physiol 120:1\u201313","journal-title":"J Gen Physiol"},{"key":"9660_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0033-0620(82)90023-8","volume":"25","author":"BN Singh","year":"1982","unstructured":"Singh BN, Hecht HS, Nademanee K, Chew CY (1982) Electrophysiologic and hemodynamic effects of slow-channel blocking drugs. Prog Cardiovasc Dis 25:103","journal-title":"Prog Cardiovasc Dis"},{"key":"9660_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1472-8206.1999.tb00333.x","volume":"13","author":"SE O'Connor","year":"1999","unstructured":"O'Connor SE, Grosset A, Janiak P (1999) The pharmacological basis and pathophysiological significance of the heart rate-lowering property of diltiazem. Fundam Clin Pharmacol 13:145\u2013153","journal-title":"Fundam Clin Pharmacol"},{"key":"9660_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.phrs.2006.03.006","volume":"53","author":"D DiFrancesco","year":"2006","unstructured":"DiFrancesco D (2006) Funny channels in the control of cardiac rhythm and mode of action of selective blockers. Pharmacol Res 53:399\u2013406","journal-title":"Pharmacol Res"},{"key":"9660_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0014-2999(84)90363-7","volume":"104","author":"W Kobinger","year":"1984","unstructured":"Kobinger W, Lillie C (1984) Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new \u201cspecific bradycardic agent\u201d. Eur J Pharmacol 104:9\u201318","journal-title":"Eur J Pharmacol"},{"key":"9660_CR8","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1161\/01.CIR.99.9.1265","volume":"99","author":"PJ Hauptman","year":"1999","unstructured":"Hauptman PJ, Kelly RA (1999) Digitalis. Circulation 99:1265\u20131270","journal-title":"Circulation"},{"key":"9660_CR9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(64)91275-9","volume":"1","author":"JW Black","year":"1964","unstructured":"Black JW, Crowther AF, Shanks RG, Smith LH, Dornhorst AC (1964) A new adrenergic betareceptor antagonist. Lancet 1:1080\u20131081","journal-title":"Lancet"},{"key":"9660_CR10","doi-asserted-by":"crossref","unstructured":"Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (1997) The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 157:2413\u20132446","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"9660_CR11","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560\u20132572","journal-title":"JAMA"},{"key":"9660_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:507\u2013520","journal-title":"JAMA"},{"key":"9660_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","volume":"359","author":"B Dahlof","year":"2002","unstructured":"Dahlof B, Devereux RB, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Devereux RB (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 359:995\u20131003","journal-title":"Lancet"},{"key":"9660_CR14","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"Group SR, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:2103\u20132116","journal-title":"N Engl J Med"},{"key":"9660_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","volume":"356","author":"L Hansson","year":"2000","unstructured":"Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, Lanke J, de Faire U, Dahl\u00f6f B, Karlberg BE (2000) Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 356:359\u2013365","journal-title":"Lancet"},{"key":"9660_CR16","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.jacc.2008.06.048","volume":"52","author":"S Bangalore","year":"2008","unstructured":"Bangalore S, Sawhney S, Messerli FH (2008) Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 52:1482\u20131489","journal-title":"J Am Coll Cardiol"},{"key":"9660_CR17","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","volume":"314","author":"ED Kantor","year":"2015","unstructured":"Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL (2015) Trends in prescription drug use among adults in the United States from 1999-2012. JAMA 314:1818\u20131831","journal-title":"JAMA"},{"issue":"135","key":"9660_CR18","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"7","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jim\u00e9nez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2017) Heart Disease and Stroke Statistics-2017 update: a report from the American Heart Association. Circulation 7(135):e146\u2013e603","journal-title":"Circulation"},{"key":"9660_CR19","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.606962","volume":"113","author":"B Williams","year":"2006","unstructured":"Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M, CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee (2006) Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113:1213\u20131225","journal-title":"Circulation"},{"key":"9660_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/HYPERTENSIONAHA.116.07250","volume":"67","author":"SF Rimoldi","year":"2016","unstructured":"Rimoldi SF, Messerli FH, Cerny D, Gloekler S, Traupe T, Laurent S, Seiler C (2016) Selective heart rate reduction with ivabradine increases central blood pressure in stable coronary artery disease. Hypertension 67:1205\u20131210","journal-title":"Hypertension"},{"key":"9660_CR21","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/S0735-1097(98)00478-1","volume":"32","author":"A Luchner","year":"1998","unstructured":"Luchner A, Burnett JC Jr, Jougasaki M, Hense HW, Riegger GA, Schunkert H (1998) Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. J Am Coll Cardiol 32:1839\u20131844","journal-title":"J Am Coll Cardiol"},{"key":"9660_CR22","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1097\/00004872-200209000-00032","volume":"20","author":"B Dahlof","year":"2002","unstructured":"Dahlof B, Zanchetti A, Diez J, Nicholls GM, Yu C-M, Barrios V, Aurup P, Smith RD, Johansson M, for the REGAAL study investigators (2002) Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J Hypertens 20:1855\u20131864","journal-title":"J Hypertens"},{"key":"9660_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","volume":"3","author":"BA Borlaug","year":"2010","unstructured":"Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM (2010) Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 3:588\u201395.21","journal-title":"Circ Heart Fail"},{"key":"9660_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/01.CIR.71.5.889","volume":"71","author":"JM Aroesty","year":"1985","unstructured":"Aroesty JM, McKay RG, Heller GV, Royal HD, Als AV, Grossman W (1985) Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. Circulation 71:889\u2013900","journal-title":"Circulation"},{"key":"9660_CR25","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.107.716886","volume":"117","author":"D Westermann","year":"2008","unstructured":"Westermann D, Kasner M, Steendijk P, Spillmann F, Riad A, Weitmann K, Hoffmann W, Poller W, Pauschinger M, Schultheiss HP, Tsch\u00f6pe C (2008) Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 117:2051\u20132060","journal-title":"Circulation"},{"key":"9660_CR26","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1093\/eurheartj\/ehp341","volume":"30","author":"R Wachter","year":"2009","unstructured":"Wachter R, Schmidt-Schweda S, Westermann D, Post H, Edelmann F, Kasner M, L\u00fcers C, Steendijk P, Hasenfuss G, Tsch\u00f6pe C, Pieske B (2009) Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure. Eur Heart J 30:3027\u20133036","journal-title":"Eur Heart J"},{"key":"9660_CR27","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147\u2013e239","journal-title":"J Am Coll Cardiol"},{"key":"9660_CR28","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1136\/hrt.37.10.1022","volume":"37","author":"F Waagstein","year":"1975","unstructured":"Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I (1975) Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37:1022\u20131036","journal-title":"Br Heart J"},{"issue":"8131","key":"9660_CR29","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S0140-6736(79)92010-5","volume":"1","author":"K Swedberg","year":"1979","unstructured":"Swedberg K, Hjalmarson A, Waagstein F, Wallentin I (1979) Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1(8131):1374\u20131376","journal-title":"Lancet"},{"key":"9660_CR30","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","volume":"342","author":"F Waagstein","year":"1993","unstructured":"Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 342:1441\u20131446","journal-title":"Lancet"},{"key":"9660_CR31","doi-asserted-by":"publisher","first-page":"43F","DOI":"10.1016\/0002-9149(86)90888-X","volume":"57","author":"JK Kjekshus","year":"1986","unstructured":"Kjekshus JK (1986) Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 57:43F\u201349F","journal-title":"Am J Cardiol"},{"key":"9660_CR32","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.jacc.2017.04.001","volume":"69","author":"D Kotecha","year":"2017","unstructured":"Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, Packer M, Coats AJS, Manzano L, B\u00f6hm M, van Veldhuisen DJ, Andersson B, Wedel H, von Lueder TG, Rigby AS, Hjalmarson \u00c5, Kjekshus J, Cleland JGF (2017) Beta-blockers in heart failure collaborative Group. Heart rate and rhythm and the benefit of Beta-blockers in patients with heart failure. J Am Coll Cardiol 69:2885\u20132896","journal-title":"J Am Coll Cardiol"},{"key":"9660_CR33","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, SHIFT Investigators (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study. Lancet 376:875\u2013885","journal-title":"Lancet"},{"key":"9660_CR34","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/eurheartj\/ehr311","volume":"32","author":"JC Tardif","year":"2011","unstructured":"Tardif JC, O'Meara E, Komajda M, B\u00f6hm M, Borer JS, Ford I, Tavazzi L, Swedberg K, SHIFT Investigators (2011) Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. Eur Heart J 32:2507\u20132515","journal-title":"Eur Heart J"},{"key":"9660_CR35","doi-asserted-by":"publisher","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","volume":"150","author":"FA McAlister","year":"2009","unstructured":"McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW (2009) Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med 150:784\u2013794","journal-title":"Ann Intern Med"},{"key":"9660_CR36","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1161\/CIRCULATIONAHA.115.017119","volume":"132","author":"N Pal","year":"2015","unstructured":"Pal N, Sivaswamy N, Mahmod M, Yavari A, Rudd A, Singh S, Dawson DK, Francis JM, Dwight JS, Watkins H, Neubauer S, Frenneaux M, Ashrafian H (2015) Effect of selective heart rate slowing in heart failure with preserved ejection fraction. Circulation 132:1719\u20131725","journal-title":"Circulation"},{"key":"9660_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","volume":"26","author":"MD Flather","year":"2005","unstructured":"Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, B\u00f6hm M, Anker SD, Thompson SG, Poole-Wilson PA, SENIORS Investigators (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26:215\u2013225","journal-title":"Eur Heart J"},{"key":"9660_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","volume":"15","author":"K Yamamoto","year":"2013","unstructured":"Yamamoto K, Origasa H, Hori M, Investigators JD (2013) Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF). Eur J Heart Fail 15:110\u2013118","journal-title":"Eur J Heart Fail"},{"key":"9660_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ijcard.2014.03.005","volume":"173","author":"K Patel","year":"2014","unstructured":"Patel K, Fonarow GC, Ekundayo OJ, Aban IB, Kilgore ML, Love TE, Kitzman DW, Gheorghiade M, Allman RM, Ahmed A (2014) Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes. Int J Cardiol 173:393\u2013401","journal-title":"Int J Cardiol"},{"key":"9660_CR40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jchf.2015.10.008","volume":"4","author":"F Edelmann","year":"2016","unstructured":"Edelmann F, Musial-Bright L, Gelbrich G, Trippel T, Radenovic S, Wachter R, Inkrot S, Loncar G, Tahirovic E, Celic V, Veskovic J, Zdravkovic M, Lainscak M, Apostolovi\u0107 S, Neskovic AN, Pieske B, D\u00fcngen HD (2016) CIBIS-ELD investigators and project multicenter trials in the competence network heart failure. Tolerability and feasibility of beta-blocker titration in HFpEF versus HFrEF: insights from the CIBIS-ELD trial. JACC Heart Fail 4:140\u2013149","journal-title":"JACC Heart Fail"},{"key":"9660_CR41","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.jacc.2013.06.043","volume":"62","author":"W Kosmala","year":"2013","unstructured":"Kosmala W, Holland DJ, Rojek A, Wright L, Przewlocka-Kosmala M, Marwick TH (2013) Effect of I f-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial. J Am Coll Cardiol 62:1330\u20131338","journal-title":"J Am Coll Cardiol"},{"key":"9660_CR42","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578","volume":"69","author":"TB Dondo","year":"2017","unstructured":"Dondo TB, Hall M, West RM, Jernberg T, Lindahl B, Bueno H, Danchin N, Deanfield JE, Hemingway H, Fox KAA, Timmis AD, Gale CP (2017) \u03b2-Blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction. J Am Coll Cardiol 69:2710\u20132720","journal-title":"J Am Coll Cardiol"},{"key":"9660_CR43","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","volume":"371","author":"K Fox","year":"2014","unstructured":"Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R, SIGNIFY Investigators (2014) Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med 371:1091\u20131099","journal-title":"N Engl J Med"},{"key":"9660_CR44","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","volume":"127","author":"S Bangalore","year":"2014","unstructured":"Bangalore S, Makani H, Radford M, Thakur K, Toklu B, Katz SD, DiNicolantonio JJ, Devereaux PJ, Alexander KP, Wetterslev J, Messerli FH (2014) Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med 127:939\u2013953","journal-title":"Am J Med"},{"key":"9660_CR45","doi-asserted-by":"publisher","first-page":"H672","DOI":"10.1152\/ajpheart.00547.2001","volume":"282","author":"P Colin","year":"2002","unstructured":"Colin P, Ghaleh B, Hittinger L, Monnet X, Slama M, Giudicelli JF, Berdeaux A (2002) Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise. Am J Physiol Heart Circ Physiol 282:H672\u2013H679","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9660_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/jpet.103.059717","volume":"308","author":"P Colin","year":"2004","unstructured":"Colin P, Ghaleh B, Monnet X, Hittinger L, Berdeaux A (2004) Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J Pharmacol Exp Ther 308:236\u2013240","journal-title":"J Pharmacol Exp Ther"},{"key":"9660_CR47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/CIRCHEARTFAILURE.113.000887","volume":"7","author":"AM Shah","year":"2014","unstructured":"Shah AM, Shah SJ, Anand IS, Sweitzer NK, O'Meara E, Heitner JF et al (2014) Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial. Circ Heart Fail 7:104\u2013115","journal-title":"Circ Heart Fail"},{"key":"9660_CR48","doi-asserted-by":"publisher","first-page":"H2882","DOI":"10.1152\/ajpheart.2001.280.6.H2882","volume":"280","author":"SC Verduyn","year":"2001","unstructured":"Verduyn SC, Ramakers C, Snoep G, Leunissen JD, Wellens HJ, Vos MA (2001) Time course of structural adaptations in chronic AV block dogs: evidence for differential ventricular remodeling. Am J Physiol Heart Circ Physiol 280:H2882\u2013H2890","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9660_CR49","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1056\/NEJMra072139","volume":"358","author":"JA Hill","year":"2008","unstructured":"Hill JA, Olson EN (2008) Cardiac plasticity. N Engl J Med 358:1370\u20131380","journal-title":"N Engl J Med"},{"key":"9660_CR50","first-page":"39","volume":"20","author":"GH Whipple","year":"1962","unstructured":"Whipple GH, Sheffield LT, Woodman EG, Theophilis C, Friedman S (1962) Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. Proc N Engl Cardiovasc Soc 20:39\u201340","journal-title":"Proc N Engl Cardiovasc Soc"},{"key":"9660_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/RES.0b013e3182582523","volume":"111","author":"SR Houser","year":"2012","unstructured":"Houser SR, Margulies KB, Murphy AM, Spinale FG, Francis GS, Prabhu SD, Rockman HA, Kass DA, Molkentin JD, Sussman MA, Koch WJ (2012) American heart association council on basic cardiovascular sciences, council on clinical cardiology, and council on functional genomics and translational biology. Animal models of heart failure: a scientific statement from the american heart association. Circ Res 111:131\u2013150","journal-title":"Circ Res"},{"key":"9660_CR52","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0735-1097(96)00592-X","volume":"29","author":"JS Shinbane","year":"1997","unstructured":"Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM (1997) Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 29:709\u2013715","journal-title":"J Am Coll Cardiol"},{"key":"9660_CR53","doi-asserted-by":"crossref","unstructured":"Tomita M, Spinale FG, Crawford FA, Zile MR (1991) Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function. Circulation 83:635\u2013644","DOI":"10.1161\/01.CIR.83.2.635"},{"key":"9660_CR54","doi-asserted-by":"publisher","first-page":"H1031","DOI":"10.1152\/ajpheart.00301.2016","volume":"311","author":"FJ Klein","year":"2016","unstructured":"Klein FJ, Bell S, Runte KE, Lobel R, Ashikaga T, Lerman LO, LeWinter MM, Meyer M (2016) Heart rate-induced modifications of concentric left ventricular hypertrophy: exploration of a novel therapeutic concept. Am J Physiol Heart Circ Physiol 311:H1031\u2013H10H9","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9660_CR55","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","volume":"110","author":"RB Devereux","year":"2004","unstructured":"Devereux RB, Dahl\u00f6f B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K (2004) Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 110:1456\u20131462","journal-title":"Circulation"},{"key":"9660_CR56","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","volume":"362","author":"IC Van Gelder","year":"2010","unstructured":"Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP, RACE II investigators (2010) Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 362:1363\u20131373","journal-title":"N Engl J Med"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-017-9660-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-017-9660-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-017-9660-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:21:16Z","timestamp":1589721676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-017-9660-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["9660"],"URL":"https:\/\/doi.org\/10.1007\/s10741-017-9660-1","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,3]]},"assertion":[{"value":"3 November 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}